Zobrazeno 1 - 10
of 690
pro vyhledávání: '"R. Veldman"'
Autor:
Haitang Jiang, Emma R. Veldman, Mikael Tiger, Carl-Johan Ekman, Johan Lundberg, Per Svenningsson
Publikováno v:
Frontiers in Neuroscience, Vol 15 (2021)
BackgroundEvidence demonstrates that brain-derived neurotrophic factor (BDNF) and S100 calcium-binding protein B (S100B) have a pivotal role in the pathogenesis of major depressive disorder (MDD) and they are proposed as predictors of antidepressant
Externí odkaz:
https://doaj.org/article/eee5bae671214392af1fa31c85f14e4d
Autor:
Ämma, Tangen, R Veldman, Emma, Jonas, Svensson, Mikael, Tiger, Nord, Magdalena, Sorjonen, Kimmo, Max, Andersson, Plavén-Sigray, Pontus, Andrea, Varrone, Christer, Halldin, Katarina, Varnäs, Jacqueline, Borg, Johan, Lundberg
Publikováno v:
International Journal of Neuropsychopharmacology. 26:241-248
Background The serotonin system has been implicated in several psychiatric disorders. All major psychiatric disorders are associated with cognitive impairment, but treatment improving cognitive deficits is lacking, partly due to limited understanding
Autor:
Emma R. Veldman, Johan Lundberg, Marie Svedberg, Balázs Gulyás, Andrea Varrone, Mikael Tiger, Katarina Varnäs, Zsolt Cselényi, Christer Halldin
Publikováno v:
Journal of Cerebral Blood Flow & Metabolism. 42:630-641
The serotonin 1B (5-HT1B) receptor has lately received considerable interest in relation to psychiatric and neurological diseases, partly due to findings based on quantification using Positron Emission Tomography (PET). Although the brainstem is an i
Autor:
Mikael Tiger, Haitang Jiang, Johan Lundberg, Emma R. Veldman, Per Svenningsson, Dejan Mamula, Carl-Johan Ekman
Publikováno v:
Journal of Affective Disorders. 290:240-244
Background Ketamine can act as antidepressant in patients with major depressive disorder (MDD) who are treatment-resistant. P11 has been implicated in ketamine's mechanism of action and proposed as biomarker for treatment response to other antidepres
Autor:
Emma R. Veldman, Per Svenningsson, Johan Lundberg, Christer Halldin, Mikael Tiger, Carl Johan Ekman
Publikováno v:
Translational Psychiatry
Translational Psychiatry, Vol 10, Iss 1, Pp 1-8 (2020)
Translational Psychiatry, Vol 10, Iss 1, Pp 1-8 (2020)
The glutamate N-methyl-d-aspartate receptor antagonist ketamine has a rapid antidepressant effect. Despite large research efforts, ketamine’s mechanism of action in major depressive disorder (MDD) has still not been determined. In rodents, the anti
Autor:
Dwivedi, Priyanka1 (AUTHOR) pdwivedi@tamu.edu, Paolella, Lionel2 (AUTHOR) l.paolella@jbs.cam.ac.uk
Publikováno v:
Academy of Management Journal. Aug2024, Vol. 67 Issue 4, p991-1023. 33p.
Publikováno v:
European Neuropsychopharmacology. 27:504-514
The serotonin 1B receptor has recently received more interest as a possible new target for pharmacological treatment of psychiatric disorders. However, the exact mechanisms of action remain unclear. This study aimed to examine the binding distributio
Publikováno v:
European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology. 27(5)
The serotonin 1B receptor has recently received more interest as a possible new target for pharmacological treatment of psychiatric disorders. However, the exact mechanisms of action remain unclear. This study aimed to examine the binding distributio
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Ung, Johnson1 (AUTHOR) ju7a@virginia.edu, Kassai, Miki2 (AUTHOR) kassaim18@ecu.edu, Tan, Su-Fern3,4 (AUTHOR) st4ub@virginia.edu, Loughran Jr., Thomas P.3,4 (AUTHOR) djf2g@virginia.edu, Feith, David J.3,4 (AUTHOR), Cabot, Myles C.2 (AUTHOR) cabotm@ecu.edu
Publikováno v:
International Journal of Molecular Sciences. Sep2024, Vol. 25 Issue 18, p9825. 24p.